GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zim Corp (OTCPK:ZIMCF) » Definitions » 14-Day RSI

Zim (ZIMCF) 14-Day RSI : N/A (As of Jun. 06, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Zim 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-06-06), Zim's 14-Day RSI is N/A.

The industry rank for Zim's 14-Day RSI or its related term are showing as below:

ZIMCF's 14-Day RSI is not ranked *
in the Biotechnology industry.
Industry Median: 46.55
* Ranked among companies with meaningful 14-Day RSI only.

Competitive Comparison of Zim's 14-Day RSI

For the Biotechnology subindustry, Zim's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zim's 14-Day RSI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zim's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Zim's 14-Day RSI falls into.



Zim  (OTCPK:ZIMCF) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zim  (OTCPK:ZIMCF) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Zim 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Zim's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Zim (ZIMCF) Business Description

Traded in Other Exchanges
N/A
Address
20 Colonade Road, Suite 200, Ottawa, ON, CAN, K2E 7M2
Zim Corp has sold its operations and is currently focused on biomedical research. The company focused all of its resources on developing intellectual property and advancing research and development in the areas of new synthetic drugs and immunotherapies. It generates geographic revenue from Canada.
Executives
John Anthony Chapman officer: Chief Financial Officer 30 HOLITZNER WAY OTTAWA A6 K2G 6V6
Filippo Scavo officer: VP Business Development 1140 STANTON ROAD OTTAWA A6 K2C 3C7
Roberto Campagna officer: VP Retail Sales
Marlen Cowpland 10 percent owner
Bill Parisi officer: VP of Business Development 1530 REINDEER WAY GREELY ONTARIO CANADA D5 K4P1N1
Favero Roderio De officer: VP of Bus Dev - Brazil RUA NILZA MEDEIROS MARTINS 200, BLOCO 4,APR 114 SAO PAULO, BRAZIL D5 05628-010
Donald Gibbs director 239 CHICAGE TRAIL MEDFORD LAKES NJ 08088
Cowpland Michael C J director, 10 percent owner, officer: Pres &, other: CEO C/O ZIM CORP 20 COLONNADE ROAD OTTAWA ONTARIO A6 K2E 7M6
Steven Houck director C/O ZIM CORP 20 COLONNADE ROAD OTTAWA, ONTARIO A6 K2E 7M6
James Stechyson director C/O ZIM CORP 20 COLONNADE ROAD OTTAWA, ONTARIO A6 K2E 7M6
Jennifer North officer: CFO, other: Secretary C/O ZIM CORP 20 COLONNADE ROAD OTTAWA ONTARIO A6 K2E 7M6
Charles Saikaley director C/O ZIM CORP 20 COLONNADE ROAD OTTAWA ONTARIO A6 K2E 7M6
Tony Davidson officer: Chief Technology Officer 74 KNUDSON DRIVE KANATA A6 K2K 2L5
Denise Batson 10 percent owner C/O ZIM CORP 20 COLONNADE ROAD, SUITE 200 NEPEAN A6 K2E 7M6

Zim (ZIMCF) Headlines

From GuruFocus

ZIM to Launch a new Mexico - Tampa Shuttle Service in December

By PRNewswire PRNewswire 11-13-2020

ZIM Announces Changes in Its Board

By PRNewswire PRNewswire 10-15-2020

ZIM Announces Financial Results For the Second Quarter of 2020

By PRNewswire PRNewswire 08-19-2020